from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0139/-

LFCtreatmentdescriptionclass of inhibitor

0.521

Amikacinug/mL Amikacintranslation

-0.381

Cap5-10ug/mL Capreomycintranslation

-0.215

Rox10-50 ug/mL Roxithromycintranslation

-0.230

SM2-5 ug/mL Streptomycintranslation

0.951

Tet5-10 ug/mL Tetracyclinetranslation

0.267

Rif0.2-5ug/mL Rifampicintranscription

0.467

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.700

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.277

CPZ10-50 ug/mL Chlorpromazinerespiration

0.656

Clofazimine10-13 ug/mL Clofaziminerespiration

0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.044

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.220

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.948

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.810

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.078

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.321

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.164

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.108

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.878

KCN5-20 ug/mL Potassium cyaniderespiration

-1.545

NaN30.2-2 mM Sodium aziderespiration

-0.100

Nigericin50 uM Nigericinrespiration

0.182

TRC10-150 ug/mL Triclosanrespiration

1.344

TRZ10-25 ug/mL Thioridazinerespiration

-0.780

Valinomycin0.5-10 uM Valinomycinrespiration

4.122

ZnSO42 mM ZnSO4respiration

-1.740

menadione6-10 ug/mL Menadionerespiration

-0.648

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.460

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.019

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.175

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.835

NRP_1Non-replicating persistence stage 1dosRassociated

0.656

Amp0.2mg/mL AmpicillincellWall

0.070

Cephalexin20-100 ug/mL CephalexincellWall

0.203

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.617

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.194

EMB10-20 ug/mL EthambutolcellWall

-0.058

Eta12-40 ug/mL EthionamidecellWall

0.237

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.436

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.144

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.062

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.205

BZA0.12 mg/mL BenzamidearomaticAmides

0.272

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.148

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.232

H2O24 mM hydrogen peroxideDNAdamaging

0.039

Levo10 ug/mL LevofloxacinDNAdamaging

0.381

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.173

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.016

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.357

UVUV-irradiationDNAdamaging

0.925

ARP41-4 ug/mL Antitubercular compound ARP4?

0.306

Antimycin12.5-50 ug/mL Antimycin A?

-0.260

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.008

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.057

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.248

PA8240.2-2 ug/mL PA-824?

-2.158

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.110

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.465

Verapamil50 uM Verapamil?

-0.523

mercaptoethanol2 mM 2-Mercaptoethanol?

0.052

methoxatin10-20 ug/mL Methoxatin?